Gene · 2071
Papers2,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Correlations between pathogenic variants in DNA repair genes and anticancer treatment efficacy in stage IV non-small cell lung cancer: A large real-world cohort and review of the literature. | Thorac Cancer | 2023 | 37095004 | PubTator, text mining | PubMed |
| Lesion recognition by XPC, TFIIH and XPA in DNA excision repair. | Nature | 2023 | 37076618 | PubTator, text mining | PubMed |
| MDM2 Inhibition Enhances Immune Checkpoint Inhibitor Efficacy by Increasing IL15 and MHC Class II Production. | Mol Cancer Res | 2023 | 37071397 | PubTator, text mining | PubMed |
| Redox dysregulation as a driver for DNA damage and its relationship to neurodegenerative diseases. | Transl Neurodegener | 2023 | 37055865 | PubTator, text mining | PubMed |
| Can accelerated ageing models inform us on age-related tauopathies? | Aging Cell | 2023 | 37013265 | PubTator, text mining | PubMed |
| SF3B1 mutations in myelodysplastic syndromes: A potential therapeutic target for modulating the entire disease process. | Front Oncol | 2023 | 37007111 | PubTator, text mining | PubMed |
| Comparing gene expression in deep infiltrating endometriosis with adenomyosis uteri: evidence for dysregulation of oncogene pathways. | Reprod Biol Endocrinol | 2023 | 37005590 | PubTator, text mining | PubMed |
| A review of treatments targeting DNA-repair gene defects in metastatic castration resistant prostate cancer. | Front Oncol | 2023 | 36998466 | PubTator, text mining | PubMed |
| Behavioral variant frontotemporal dementia in a 23-year-old man. | Neurocase | 2023 | 36998234 | PubTator, text mining | PubMed |
| Excessive reactive oxygen species induce transcription-dependent replication stress. | Nat Commun | 2023 | 36997515 | PubTator, text mining | PubMed |
| Racial Disparities in Pathological Complete Response Among Patients Receiving Neoadjuvant Chemotherapy for Early-Stage Breast Cancer. | JAMA Netw Open | 2023 | 36995716 | PubTator, text mining | PubMed |
| Genetic Networks of Alzheimer's Disease, Aging, and Longevity in Humans. | Int J Mol Sci | 2023 | 36982253 | PubTator, text mining | PubMed |
Clinical trial on the efficacy and safety of NPC-15 for patients with xeroderma pigmentosum exaggerated sunburn reaction type: XP-1 study protocol for a multicentre, double-blinded, placebo-controlled, two-group crossover study followed by a long-term open study in Japan. | BMJ Open | 2023 | 36948554 | PubTator, text mining | PubMed |
| Germline pathogenic variants in patients with early-onset neuroendocrine neoplasms. | Endocr Relat Cancer | 2023 | 36947458 | PubTator, text mining | PubMed |
| Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous system. | Neurooncol Adv | 2023 | 36915613 | PubTator, text mining | PubMed |
| Real-world performance analysis of a novel computational method in the precision oncology of pediatric tumors. | World J Pediatr | 2023 | 36914906 | PubTator, text mining | PubMed |
| Hereditary cancer syndromes. | World J Clin Oncol | 2023 | 36908677 | PubTator, text mining | PubMed |
| DNA Alkylation Damage by Nitrosamines and Relevant DNA Repair Pathways. | Int J Mol Sci | 2023 | 36902118 | PubTator, text mining | PubMed |
| DNA Repair Deficiency Regulates Immunity Response in Cancers: Molecular Mechanism and Approaches for Combining Immunotherapy. | Cancers (Basel) | 2023 | 36900418 | PubTator, text mining | PubMed |
| A disease-associated XPA allele interferes with TFIIH binding and primarily affects transcription-coupled nucleotide excision repair. | Proc Natl Acad Sci U S A | 2023 | 36893274 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2071/papers?page=10